Intelgenx Technologies Corp (IGXT)
0.167
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Intelgenx Technologies Total Liabilities (Quarterly): 20.53M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 20.53M |
September 30, 2023 | 19.02M |
June 30, 2023 | 16.98M |
March 31, 2023 | 16.65M |
December 31, 2022 | 12.61M |
September 30, 2022 | 12.48M |
June 30, 2022 | 12.54M |
March 31, 2022 | 17.42M |
December 31, 2021 | 14.03M |
September 30, 2021 | 15.43M |
June 30, 2021 | 13.58M |
March 31, 2021 | 13.29M |
December 31, 2020 | 12.07M |
September 30, 2020 | 10.68M |
June 30, 2020 | 10.13M |
March 31, 2020 | 9.993M |
December 31, 2019 | 10.73M |
September 30, 2019 | 10.43M |
June 30, 2019 | 10.39M |
March 31, 2019 | 10.52M |
December 31, 2018 | 10.03M |
September 30, 2018 | 10.60M |
June 30, 2018 | 10.42M |
March 31, 2018 | 9.033M |
December 31, 2017 | 9.318M |
Date | Value |
---|---|
September 30, 2017 | 10.38M |
June 30, 2017 | 5.398M |
March 31, 2017 | 6.529M |
December 31, 2016 | 7.845M |
September 30, 2016 | 8.623M |
June 30, 2016 | 4.592M |
March 31, 2016 | 3.018M |
December 31, 2015 | 3.352M |
September 30, 2015 | 1.784M |
June 30, 2015 | 1.47M |
March 31, 2015 | 1.496M |
December 31, 2014 | 1.711M |
September 30, 2014 | 0.702M |
June 30, 2014 | 0.778M |
March 31, 2014 | 0.872M |
December 31, 2013 | 1.209M |
September 30, 2013 | 1.007M |
June 30, 2013 | 1.105M |
March 31, 2013 | 1.345M |
December 31, 2012 | 1.981M |
September 30, 2012 | 1.252M |
June 30, 2012 | 1.283M |
March 31, 2012 | 1.396M |
December 31, 2011 | 0.666M |
September 30, 2011 | 0.376M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.993M
Minimum
Mar 2020
20.53M
Maximum
Dec 2023
13.63M
Average
12.61M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Lexaria Bioscience Corp | 0.2042M |
Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 8.282M |
Shareholders Equity (Quarterly) | -12.25M |
Debt to Equity Ratio | -1.216 |
Current Ratio | 0.4085 |
Net Debt Paydown Yield | -4.29% |